Table 4.
Background and ART outcomes of the patients who received double oocyte pickup (OPU)
| Patients, n | 13 |
| Age, yearsa | 41.6 |
| AMH values, ng/mLa | 0.47 |
| Basal follicle‐stimulating hormone values, IU/La | 15.1 |
| Ovarian stimulation: natural/CC/CC + hMG, n | 3/5/5 |
| First maturation trigger: hCG/GnRH‐a, n | 7/6 |
| Ovarian stimulation after the first OPU: hMG/CC, n | 9/4 |
| Second maturation trigger: hCG/GnRH‐a, n | 9/4 |
| Progesterone concentration on the day of the second maturation trigger, ng/mla | 15.6 |
| Number of retrieved oocytes on the first OPU, na | 1.3 |
| Number of MII oocytes on the first OPU, na | 1.1 |
| Percentage of MII oocytes on the first OPU, % | 62.5 |
| Number of fertilized oocytes on the first OPU, na | 1.1 |
| Percentage of MGQ embryos on the first OPU, % | 33.3 |
| Number of retrieved oocytes on the second OPU, na | 1.2 |
| Number of MII oocytes on the second OPU, na | 1.2 |
| Percentage of the MII oocytes on the second OPU, % | 100 |
| Number of fertilized oocytes on the second OPU, na | 0.9 |
| Percentage of MGQ embryos on the second OPU, na | 25.0 |
| Total number of collected oocytes, na | 2.5 |
| Number of patients who acquired cryopreserved embryos, n | 12 |
AMH, anti‐Müllerian hormone; CC, clomiphene citrate; hMG, human menopausal gonadotropin; hCG, human chorionic gonadotropin; GnRH‐a, gonadotropin‐releasing hormone‐agonist; MGQ, morphologically good quality.
a
Mean.